Alto Neuroscience (ANRO) Depreciation & Amortization (CF) (2023 - 2025)

Alto Neuroscience has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $200000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696000.0 (down 0.57% YoY) and the FY2025 annual result came in at $700000.0, up 40.0% from the prior year.
• Depreciation & Amortization (CF) rose to $200000.0 in Q1 2026 per ANRO's latest filing, from $196000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $200000.0 in Q3 2024 and troughed at $73000.0 in Q4 2023.
• A 4-year average of $142692.3 and a median of $100000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) jumped 173.97% in 2024, then decreased 2.0% in 2025.
• Over 4 years, Depreciation & Amortization (CF) stood at $73000.0 in 2023, then soared by 173.97% to $200000.0 in 2024, then slipped by 2.0% to $196000.0 in 2025, then climbed by 2.04% to $200000.0 in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $200000.0, $196000.0, and $200000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.